Month: September 2024

PLOT: An aging actress (Demi Moore) is given access to “The Substance,” which, if injected, is supposed to give her access to a younger, perfect version of herself. However, the substance also had certain rules to follow, and when she violates them, disaster soon follows.

REVIEW: The Substance was the unexpected toast of Cannes when it played there back in the spring. Critics hailed director Coralie Fargeat’s maximalist take on body horror, with many praising the fearless lead performances from Demi Moore and Margaret Qualley. I went into it expecting a solid little horror satire, but I didn’t think I’d be watching the greatest body horror movie made since the heyday of David Cronenberg.

Fargeat’s movie offers Demi Moore one of her career’s best (and most grotesque) roles. She plays Elisabeth Sparkle, a one-time movie star who’s now best known for hosting a popular morning workout show. On her birthday, she’s fired by her repulsive boss (Dennis Quaid – chewing the scenery and nailing the assignment), with the new directive being that they need to hire someone young and “fresh” to take her place. 

Then, she’s approached and given access to “The Substance”, which offers her a Faustian bargain. If she injects “The Substance”, a younger, more physically perfect body will grow out of her (with her spinal column cracking open like an egg). The rule is that her younger version can only be sustained on her own for a week at a time. One week, the young version of Elizabeth, “Sue” (Margaret Qualley), gets to roam free while Elizabeth is in stasis. The next week – and vice versa. They share a consciousness/ If they violate this rule (which they soon do), the result is a complete and utter disaster.

At 140 minutes, The Substance is a slow burn as far as the horror aspect goes, with it more of a satire of Hollywood’s preoccupation with youth for the first half. As “Sue,” the younger version of Elizabeth, Margaret Qualley, is vivacious and easily manages to usurp Elizabeth’s former fame when she goes to work at her old network. Yet, despite sharing the same consciousness, the two halves grow jealous of each other, with Sue attempting to take more ownership over her life and body. The result is a physical and mental disaster for Elizabeth, who starts to resemble Jeff Goldblum in The Fly, with the prosthetic effects used impressively repulsive.

Unlike Cronenberg’s body horror films, Fargeat is more invested in the satiric angle (rather than the tragedy). The gore becomes so repulsive and over-the-top towards the end that the critic’s screening I attended grew increasingly raucous. Older audiences drawn in by Moore’s presence will be challenged by how “out there” this is, but younger genre audiences will eat this up, as it’s a real hoot.

The Substance, review, Demi Moore

Moore is perfectly cast and certainly fearless in the lead. Still gorgeous at sixty-two, Moore’s casting is ingenious, as anyone who grew up in the nineties no doubt remembers how her body and beauty were something the media obsessed over. If anyone knows how youth and beauty are currency in Hollywood, it’s her. As good as she’s been in plenty of movies, Moore has never had a role like this, which is like a 21st-century modern horror version of the types of roles once played by Bette Davis and Joan Crawford. This might be her What Ever Happened to Baby Jane. The fact that Moore obviously still looks so flawless makes the whole caveat that execs like the one played by Quaid think she’s over the hill somewhat of a gag unto itself. Certainly, the character played by Quaid, who’s not coincidently named Harvey (a la Weinstein), is a caricature of a very real kind of man that exists in Tinseltown. Still, the real problem here is also shown to be Elizabeth’s self-worth, which seems totally wrapped up in the adulation she receives from men and her (once) adoring public.

Margaret Qualley, as the younger version of the character, is similarly fearless, with her dazzling beauty nearly weaponizing her as Sue takes over Elizabeth’s life. Qualley’s one of those actresses who has always been nervy enough to deliver “big” performances without ever seeming self-conscious about her choices. I couldn’t imagine anyone else pulling off the turn she does here, with her and Moore perfectly complimenting each other despite rarely sharing the screen. In addition to the propulsive pace (the 140 minutes run by) and the visual style, Fargeat really emerges as one of the great new voices in horror. 

Indeed, The Substance will be extremely controversial when it comes out, but it’s getting an ideal launching pad as the opening night movie at TIFF’s Midnight Madness. MUBI, who picked this up at Cannes, likely has their biggest movie ever on their hands, and I wouldn’t be surprised if it becomes a major indie hit. 

The Substance


The Substance

AMAZING

9

The post The Substance (TIFF) Review appeared first on JoBlo.

jamie foxx

It has been well over a year since Jamie Foxx experienced what was being called a “medical complication.” And considering how little we still know about it, it’s still being referred to as that. But next month, Jamie Foxx will open up about his “serious health scare” – and more – in a new one-man special called One More Chance.

Jamie Foxx posted the information on social media this week along with white text over a black background that read, “WHAT HAD HAPPENED WAS”. The post read, in part: “Join us for an unforgettable one-man show as Jamie Foxx takes the stage to share his journey through a serious health scare, filled with humor, heart, and inspiration! Experience Jamie Foxx like never before in this intimate and engaging performance, as he opens up about his struggles, triumphs, and everything in between. Get ready for a night of laughter, reflection, and genuine connection. Don’t miss this exclusive one-man show, “One More Chance: An Evening with Jamie Foxx”! Ticket information coming soon.” The shows will be held on October 3rd, 4th and 5th, all in Atlanta.

With the tease of “WHAT HAD HAPPENED WAS” and the title of the show being One More Chance, we can likely expect Jamie Foxx to delve as deep into his “medical complication” as he has up to this point and see just how it affected him long term. Earlier this summer, Foxx told a small crowd that he was “gone for 20 days”, the most shocking of any information we had heard.

Considering we know Jamie Foxx more for his big screen performances, many of us may have forgotten (or never knew) that he has a history of stand-up, taking the stage for the first time back in the late ‘80s. And we can see this being a perfect venue for Foxx to present the story in a controlled environment under his own terms (we wouldn’t be surprised if phones get locked up prior). It, too, will undoubtedly be one of the most buzzed-about pop culture events of the year.

The post Jamie Foxx will open up about “serious health scare” in one-man show appeared first on JoBlo.

After a quiet couple of weeks, the box office is about to get a shot of excitement, with Tim Burton’s long-awaited Beetlejuice Beetlejuice set to rule the roost (read our review). While everyone is reasonably sure that it will top the box office this weekend, the predictions as far as how much money it will make have been all over the map. Note that the original film made $74 million in 1988, which, to adjust for inflation, would be just shy of $200 million nowadays. It was more of a sleeper than a massive blockbuster, but it became a timeless classic on home video and cable.

Some box office gurus think the sequel has a good chance of opening in the $100 million range. While I really enjoyed the sequel, I think it’ll do more along the lines of $50-60 million, which is only about half of what Box Office Pro is predicting. I’m being conservative in my estimates because I find it troubling when everyone expects a monster hit. Then, if it happens to perform just well enough, everyone dubs it a disappointment. An opening in this range would be healthy for Burton’s movie, but if it makes more, that would be great! 

Otherwise, the holdovers should be the usual suspects, with Deadpool & Wolverine on track to make about $7 million. Hot on its heels will be the Blake Lively romance, It Ends With Us, which should do about $6 million, while Alien: Romulus should be starting to wrap up its box office run with about $5 million, while Reagan should round out the top five with about $4 million.

Here are my predictions:

  1. Beetlejuice Beetlejuice: $60 million
  2. Deadpool & Wolverine: $7 million
  3. It Ends With Us: $6 million
  4. Alien: Romulus: $5 million
  5. Reagan: $4 million

Do you think I’m way off as far as Beetlejuice Beetlejuice goes? Let us know in the comments! 

The post Box Office Predictions: Beetlejuice Beetlejuice going in for an easy win appeared first on JoBlo.

I cried at the end of Astro Bot. I recognize this isn’t indicative of much beyond my sentimentality, but I thought it was a crucial tidbit to underscore something else, something important about PlayStation’s excellent new platformer. It really is, more than anything else, a celebration of the consoles and games that…

Read more…

I cried at the end of Astro Bot. I recognize this isn’t indicative of much beyond my sentimentality, but I thought it was a crucial tidbit to underscore something else, something important about PlayStation’s excellent new platformer. It really is, more than anything else, a celebration of the consoles and games that…

Read more…

George R.R. Martin, House of the Dragon, season 2, HBO

It’s not always easy to adapt a novel to film or television, and no matter how faithful you are to the source material, chances are you’re going to piss someone off anyway. In the case of House of the Dragon, none other than author George R.R. Martin took aim at the second season of the HBO series in a since-deleted blog post, warning that changes made in the show will cause problems later in the story.

It may be a little embarrassing to have the creator of one of your biggest franchises publically criticize it, and HBO has now responded to Martin’s post. “There are few greater fans of George R.R. Martin and his book Fire & Blood than the creative team on House of the Dragon, both in production and at HBO,” the statement reads. “Commonly, when adapting a book for the screen, with its own format and limitations, the showrunner ultimately is required to make difficult choices about the characters and stories the audience will follow. We believe that Ryan Condal and his team have done an extraordinary job and the millions of fans the series has amassed over the first two seasons will continue to enjoy it.

In the post, Martin detailed his opposition to reducing the number of Aegon and Helaena’s children from three to two. While this doesn’t seem like the most egregious change, Martin believes it will have a “butterfly effect” on later seasons.

I argued against it, for all these reasons. I did not argue long, or with much heat, however. The change weakened the sequence, I felt, but only a bit. And Ryan had what seemed to be practical reasons for it; they did not want to deal with casting another child, especially a two-year old toddler. Kids that young will inevitably slow down production, and there would be budget implications,” Martin wrote. “Budget was already an issue on HOUSE OF THE DRAGON, it made sense to save money wherever we could. Moreover, Ryan assured me that we were not losing Prince Maelor, simply postponing him. Queen Helaena could still give birth to him in season three, presumably after getting with child late in season two. That made sense to me, so I withdrew my objections and acquiesced to the change.” Martin added, “Sometime between the initial decision to remove Maelor, a big change was made. The prince’s birth was no longer just going to be pushed back to season 3. He was never going to be born at all. The younger son of Aegon and Helaena would never appear.

Time will tell whether this change will prove detrimental to future seasons of House of the Dragon, but as the creator of the franchise, Martin is certainly entitled to be protective of his sprawling saga and all its characters.

The post HBO responds to George R.R. Martin’s criticisms of House of the Dragon season 2 appeared first on JoBlo.